Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Holte, Harald  [Clear All Filters]
Journal Article
Leivonen S-K, Friman T, Autio M, Vaittinen S, Jensen AWind, D'Amore F, Hamilton-Dutoit SJacques, Holte H, Beiske K, Kovanen PE, et al. Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. Haematologica. 2023.
Smeland KB, Kiserud CE, Lauritzsen GF, Fagerli U-M, Falk RS, Fluge Ø, Fosså A, Kolstad A, Loge JH, Maisenhölder M, et al. Conditional survival and excess mortality after high dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica. 2015.
Murbraech K, Holte E, Broch K, Smeland KB, Holte H, Rösner A, Lund MBrit, Dalen H, Kiserud C, Aakhus S. Impaired Right Ventricular Function in Long-Term Lymphoma Survivors. J Am Soc Echocardiogr. 2016.
Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, et al. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2021.
Maziarz RT, Waller EK, Jaeger U, Fleury I, McGuirk J, Holte H, Jaglowski S, Schuster SJ, Bishop MR, Westin JR, et al. Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Adv. 2020;4(4):629-637.
Murbraech K, Wethal T, Smeland KB, Holte H, Loge JHåvard, Holte E, Rösner A, Dalen H, Kiserud CE, Aakhus S. Valvular Dysfunction in Lymphoma Survivors Treated with Autologous Stem Cell Transplantation: A National Cross-Sectional Study. JACC Cardiovasc Imaging. 2016.